Search - tctmd.com

Displaying 81 - 100 of 533

Sort: Relevancy | Date

Presentation TCT 2023

TCT 720: Patient-Reported Outcomes in Tricuspid Valve Intervention: Patient Preference Results from the TRISCEND II Trial

Presenter: Colin Barker

October 26, 2023

TCT 768: Early echocardiographic and hemodynamic changes after caval aortic valve implantation for severe tricuspid regurgitation

Presentation TCT 2023

TCT 768: Early Echocardiographic and Hemodynamic Changes After Caval Valve Implantation

Presenter: Ottavia Cozzi

October 26, 2023

Presentation TCT 2023

TCT 513: Real-world Clinical Outcomes and Health Care Utilization in Patients with Severe Tricuspid Regurgitation

Presenter: Mahesh Madhavan

October 26, 2023

Presentation TCT 2023

TCT 500: Computed Tomography Anatomic Predictors of Procedural Success in Patients Undergoing Tricuspid Transcatheter Edge-to-Edge Repair.

Presenter: Joanna Bartkowiak

October 26, 2023

News Conference News TCT 2023

ALIGN-AR: Positive Results for Trilogy Valve in Aortic Regurgitation

Todd Neale

October 26, 2023

Presentation TCT 2023

TCT 689: 30-Day Readmissions of Percutaneous Mechanical Aspiration of Tricuspid Valve Vegetation

Presenter: Cody Morgan Boyer-Sprouse

October 26, 2023

Presentation TCT 2023

TCT 665: A Real-World Comparative Analysis of Surgical and Transcatheter Approaches to Tricuspid Regurgitation

Presenter: Federica Gramegna

October 26, 2023

Presentation TCT 2023

TCT 340: Sex Differences in Patients with Three-vessel Coronary Artery Disease Undergoing FFR-guided PCI or CABG: A Pre-specified Analysis of the FAME 3 Trial

Presenter: Kuniaki Takahashi

October 26, 2023

Presentation TCT 2023

TCT 183: Multi-state Modeling of Tricuspid Regurgitation Disease Progression Rate using an EHR-integrated Natural Language Processing Platform

Presenter: Omar Khalique

October 26, 2023

Presentation TCT 2023

TCT 97: Temporal Improvement in Outcomes of Isolated Tricuspid Repair: Evidence from Meta-Analysis and Meta-Regression

Presenter: Garrett Welle

October 26, 2023

Presentation TCT 2023

Structural Keynote Lecture: Essentials of Lifetime Management of Aortic Disease in 2023

Presenter: Eberhard Grube

October 26, 2023

Presentation TCT 2023

TCT 68: Cardiac Implantable Electronic Device Lead-Related Tricuspid Regurgitation in Patients Presenting for Transcatheter Tricuspid Valve Interventions

Presenter: Baban Kumar

October 26, 2023

News Conference News TCT 2023

No Mortality Signal for iFR in Real-world Use: SWEDEHEART

Caitlin E. Cox

October 26, 2023

Presentation TCT 2023

TCT 760: Transcatheter Edge-to-Edge Repair for Tricuspid Regurgitation- A Systematic Review and Meta Analysis

Presenter: Irfan Ullah

October 26, 2023

Presentation TCT 2023

TCT 597: Transcatheter Tricuspid Valve Replacement: From Preclinical to Early First-in-Human Experiences with the MonarQ Device

Presenter: Arshad Quadri

October 26, 2023

Presentation TCT 2023

TCT 458: Outcomes and Trends of Transcatheter Edge to Edge Repair in the Mitral Valve Prolapse

Presenter: Aneeza Jamshed

October 26, 2023

Presentation TCT 2023

TCT 311: Impact of residual tricuspid regurgitation on right ventricular reverse remodeling in patients undergoing tricuspid valve intervention

Presenter: Ludwig Weckbach

October 26, 2023

Presentation TCT 2023

TCT 287: Echocardiographic Analysis of Angiovac Treatment for Infective Endocarditis: a Single Center Experience

Presenter: Danial Saleem

October 26, 2023

Presentation TCT 2023

TCT 96: Association Between Polyvascular Disease and Transcatheter Aortic Valve Replacement Outcomes: Insights From the STS/ACC TVT Registry

Presenter: Kannu Bansal

October 26, 2023

Presentation TCT 2023

TCT 233: One-year outcomes after CE-marked approved bicaval-valve system implantation in patients with severe tricuspid regurgitation.

Presenter: Ignacio Amat-Santos

October 26, 2023

Advertisement

TCT 720: Patient-Reported Outcomes in Tricuspid Valve Intervention: Patient Preference Results from the TRISCEND II Trial

TCT 768: Early Echocardiographic and Hemodynamic Changes After Caval Valve Implantation

TCT 513: Real-world Clinical Outcomes and Health Care Utilization in Patients with Severe Tricuspid Regurgitation

TCT 500: Computed Tomography Anatomic Predictors of Procedural Success in Patients Undergoing Tricuspid Transcatheter Edge-to-Edge Repair.

ALIGN-AR: Positive Results for Trilogy Valve in Aortic Regurgitation

TCT 689: 30-Day Readmissions of Percutaneous Mechanical Aspiration of Tricuspid Valve Vegetation

TCT 665: A Real-World Comparative Analysis of Surgical and Transcatheter Approaches to Tricuspid Regurgitation

TCT 340: Sex Differences in Patients with Three-vessel Coronary Artery Disease Undergoing FFR-guided PCI or CABG: A Pre-specified Analysis of the FAME 3 Trial

TCT 183: Multi-state Modeling of Tricuspid Regurgitation Disease Progression Rate using an EHR-integrated Natural Language Processing Platform

TCT 97: Temporal Improvement in Outcomes of Isolated Tricuspid Repair: Evidence from Meta-Analysis and Meta-Regression

Structural Keynote Lecture: Essentials of Lifetime Management of Aortic Disease in 2023

TCT 68: Cardiac Implantable Electronic Device Lead-Related Tricuspid Regurgitation in Patients Presenting for Transcatheter Tricuspid Valve Interventions

No Mortality Signal for iFR in Real-world Use: SWEDEHEART

TCT 760: Transcatheter Edge-to-Edge Repair for Tricuspid Regurgitation- A Systematic Review and Meta Analysis

TCT 597: Transcatheter Tricuspid Valve Replacement: From Preclinical to Early First-in-Human Experiences with the MonarQ Device

TCT 458: Outcomes and Trends of Transcatheter Edge to Edge Repair in the Mitral Valve Prolapse

TCT 311: Impact of residual tricuspid regurgitation on right ventricular reverse remodeling in patients undergoing tricuspid valve intervention

TCT 287: Echocardiographic Analysis of Angiovac Treatment for Infective Endocarditis: a Single Center Experience

TCT 96: Association Between Polyvascular Disease and Transcatheter Aortic Valve Replacement Outcomes: Insights From the STS/ACC TVT Registry

TCT 233: One-year outcomes after CE-marked approved bicaval-valve system implantation in patients with severe tricuspid regurgitation.

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content